Connect with us


Brisbane biotech company trials drug on US COVID-19 patients in bid to find ‘new way to prevent people dying’ of virus




A Brisbane biotech company, led by award-winning immunologist Ian Frazer, has created an anti-inflammatory drug, which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States.

The new drug is not a vaccine but rather a treatment being trialled, and if proven successful, could become part of routine care in serious cases to prevent people dying from the virus.

Professor Frazer, who was the…

Click here to view the original article.

Continue Reading

You might also like ...

Toxic lead levels in garden soils across Australia, study finds
Elon Musk’s SpaceX SN15 rocket ship successfully launches and lands